Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0001 USD | +9.900,00% | -.--% | -.--% |
2015 | Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015 | |
2015 | Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015 |
Omzet 2013 | 16,48 mln. 15,36 mln. | Omzet 2014 | 14,01 mln. 13,05 mln. | Marktkapitalisatie | 3,66 mln. 3,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -4 mln. -3,73 mln. | Nettowinst (verlies) 2014 | -7 mln. -6,52 mln. | EV/omzet 2013 | 0,4 x |
Nettoschuld 2013 | 3,04 mln. 2,84 mln. | Nettoschuld 2014 | 4,62 mln. 4,3 mln. | EV/omzet 2014 | 0,59 x |
K/w-verhouding 2013 |
-0,8
x | K/w-verhouding 2014 |
-0,49
x | Werknemers | 61 |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
1 dag | +9.900,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 01-04-15 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 16-06-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Sidney Emery
BRD | Director/Board Member | 74 | 01-10-05 |
Director/Board Member | 57 | 06-08-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 2,13K | |
+7,71% | 218 mld. | |
+6,25% | 182 mld. | |
+10,60% | 132 mld. | |
+26,73% | 108 mld. | |
-0,57% | 62,51 mld. | |
+15,42% | 52,98 mld. | |
-1,89% | 47,59 mld. | |
-1,91% | 39,96 mld. | |
+11,16% | 39,22 mld. |